SEK 0.87
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 21.07 Million SEK | 13.26% |
2022 | 18.6 Million SEK | 51.1% |
2021 | 12.31 Million SEK | 4926.12% |
2020 | 245 Thousand SEK | 0.0% |
2019 | - SEK | 0.0% |
2018 | - SEK | 100.0% |
2017 | -1.00 SEK | -100.0% |
2016 | 24.08 Million SEK | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 5.24 Million SEK | -29.36% |
2024 Q2 | 5.31 Million SEK | 1.37% |
2023 FY | 21.07 Million SEK | 13.26% |
2023 Q2 | 5.11 Million SEK | 52.75% |
2023 Q3 | 5.19 Million SEK | 1.57% |
2023 Q4 | 7.42 Million SEK | 43.06% |
2023 Q1 | 3.34 Million SEK | 0.0% |
2022 Q2 | -1.00 SEK | 0.0% |
2022 FY | 18.6 Million SEK | 51.1% |
2022 Q4 | - SEK | 0.0% |
2022 Q3 | - SEK | 100.0% |
2022 Q1 | - SEK | 0.0% |
2021 Q4 | - SEK | 0.0% |
2021 FY | 12.31 Million SEK | 4926.12% |
2021 Q3 | - SEK | 0.0% |
2020 FY | 245 Thousand SEK | 0.0% |
2019 FY | - SEK | 0.0% |
2018 FY | - SEK | 100.0% |
2017 FY | -1.00 SEK | -100.0% |
2016 FY | 24.08 Million SEK | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
BrainCool AB (publ) | -42.04 Million SEK | 150.123% |
Neola Medical AB (publ) | 17.64 Million SEK | -19.433% |